ATP7A Antibody Blocking Peptide

Product Discontinued

ATP7A Antibody Blocking Peptide Summary

• Description: A human ATP7A antibody blocking peptide.

  Source: Synthetic

  (Accession #: NP_000043)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: ATP7A
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-54906. This synthetic peptide is designed for use in an antibody competition assay with its corresponding antibody. Use of this product in any other assay has not yet been tested.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: Lyophilized with sterile distilled water.
• Preservative: No Preservative
• Concentration: LYOPH
• Purity: N/A
• Reconstitution Instructions: Reconstitute with 100ul of sterile PBS for a final peptide concentration of 1 mg/ml.

Notes

For longer periods of storage, aliquot and store at -20C. Avoid repeat freeze-thaw cycles.

Alternate Names for ATP7A Antibody Blocking Peptide

• ATPase, Cu++ transporting, alpha polypeptide
• Copper pump 1
• copper-transporting ATPase 1
• Cu++-transporting P-type ATPase
• DSMAX
• EC 3.6.3
• EC 3.6.3.4
• MC1
• Menkes disease-associated protein
• Menkes syndrome
• MK
• MNKFLJ17790
• OHS
• SMAX3

Background

The ATP7A gene encodes the Menkes copper-translocating P-type ATPase, a ubiquitous protein that regulates the absorption of copper in the gastrointestinal tract. Inside cells, this protein has a dual function: it delivers copper to cuproenzymes in the Golgi compartment and effluxes excess copper. The trafficking mechanism and catalytic activity combine to facilitate absorption and intercellular transport of copper. Menkes disease, a systemic copper deficiency disorder, is caused by mutations in the ATP7A gene.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Publications for ATP7A Protein (NBP1-54906PEP)(1)

Publication using NBP1-54906PEP

• Schoonover KE, Roberts RC Markers of copper transport in the cingulum bundle in schizophrenia Schizophrenia research 2021-01-09 [PMID: 33434726] (AC, Human)

Bioinformatics

• Gene Symbol: ATP7A